Posted in | News | Nanomedicine

Arrowhead to Discuss its Nanomedicine Portfolio at Bio Investor Forum

From Arrowhead PharmaceuticalSep 29 2010

Arrowhead Research Corporation (NASDAQ:ARWR) today announced that Dr. Christopher Anzalone, Chief Executive Officer, will be presenting at the 9th Annual BIO Investor Forum at 4:30 p.m. PT on Tuesday, October 5, 2010, at the Palace Hotel in San Francisco, CA.

Dr. Anzalone will be discussing the Company and its increased focus on its nanomedicine portfolio, including clinical results.

The BIO Investor Forum is a national investor conference featuring private and emerging public companies. The meeting attracts healthcare venture capital and public market investors and research analysts. In addition, the BIO Investor Forum draws business development executives from global pharmaceutical and biotechnology companies.

Source: http://www.arrowheadresearch.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

APA
Arrowhead Pharmaceutical. (2019, February 13). Arrowhead to Discuss its Nanomedicine Portfolio at Bio Investor Forum. AZoNano. Retrieved on April 19, 2024 from https://www.azonano.com/news.aspx?newsID=19751.
MLA
Arrowhead Pharmaceutical. "Arrowhead to Discuss its Nanomedicine Portfolio at Bio Investor Forum". AZoNano. 19 April 2024. <https://www.azonano.com/news.aspx?newsID=19751>.
Chicago
Arrowhead Pharmaceutical. "Arrowhead to Discuss its Nanomedicine Portfolio at Bio Investor Forum". AZoNano. https://www.azonano.com/news.aspx?newsID=19751. (accessed April 19, 2024).
Harvard
Arrowhead Pharmaceutical. 2019. Arrowhead to Discuss its Nanomedicine Portfolio at Bio Investor Forum. AZoNano, viewed 19 April 2024, https://www.azonano.com/news.aspx?newsID=19751.